Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 8, 2008 - Issue 8
Submit an article Journal homepage
115
Views
10
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial

Richard Adams Velindre Hospital Cancer Centre, Velindre Road, Whitchurch, Cardiff, CF14 2TL, UK. [email protected]
,
Angela Meade MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK. [email protected]
,
Harpreet Wasan Department of Oncology, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK. [email protected]
,
Gareth Griffiths Wales Cancer Trials Unit, Department Primary Care & Public Health, 6th Floor Neuadd Meirionnydd, School of Medicine, Cardiff University, Cardiff, UK. [email protected]
&
Tim Maughan Velindre Hospital Cancer Centre, Velindre Road, Whitchurch, Cardiff, CF14 2TL, UK. [email protected]
Pages 1237-1245 | Published online: 10 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Anshu Wadhawan, Richard Stephens & Richard Adams. (2009) Intermittent therapy in the palliative treatment of metastatic colorectal cancer. Expert Review of Anticancer Therapy 9:1, pages 125-134.
Read now

Articles from other publishers (9)

Daeyoun David Won, Jae Im Lee, In Kyu Lee, Seong-Taek Oh, Eun Sun Jung & Sung Hak Lee. (2017) The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients. BMC Cancer 17:1.
Crossref
Andrés López-Cortés, Santiago Guerrero, María Redal, Angel Alvarado & Luis Quiñones. (2017) State of Art of Cancer Pharmacogenomics in Latin American Populations. International Journal of Molecular Sciences 18:6, pages 639.
Crossref
Michitaka Ozaki, Takeaki Ozawa & Yuma Yamada. 2015. Innovative Medicine. Innovative Medicine 265 279 .
Daniela Martinetti, Rosario Costanzo, Shahin Kadare, Mehdiu Alimehmeti, Cristina Colarossi, Vincenzo Canzonieri, Massimiliano Berretta & Lorenzo Memeo. (2014) KRAS and BRAF mutational status in colon cancer from Albanian patients. Diagnostic Pathology 9:1.
Crossref
Andrea Manca, Christian Asseburg, Yolanda Bravo Vergel, Matt T. Seymour, Angela Meade, Richard Stephens, Mahesh Parmar & Mark J. Sculpher. (2012) The Cost-Effectiveness of Different Chemotherapy Strategies for Patients with Poor Prognosis Advanced Colorectal Cancer (MRC FOCUS). Value in Health 15:1, pages 22-31.
Crossref
Ian P. M. Tomlinson, Luis G. Carvajal-Carmona, Sara E. Dobbins, Albert Tenesa, Angela M. Jones, Kimberley Howarth, Claire Palles, Peter Broderick, Emma E. M. Jaeger, Susan Farrington, Annabelle Lewis, James G. D. Prendergast, Alan M. Pittman, Evropi Theodoratou, Bianca Olver, Marion Walker, Steven Penegar, Ella Barclay, Nicola Whiffin, Lynn Martin, Stephane Ballereau, Amy Lloyd, Maggie Gorman, Steven Lubbe, Bryan Howie, Jonathan Marchini, Clara Ruiz-Ponte, Ceres Fernandez-Rozadilla, Antoni Castells, Angel Carracedo, Sergi Castellvi-Bel, David Duggan, David Conti, Jean-Baptiste Cazier, Harry Campbell, Oliver Sieber, Lara Lipton, Peter Gibbs, Nicholas G. Martin, Grant W. Montgomery, Joanne Young, Paul N. Baird, Steven Gallinger, Polly Newcomb, John Hopper, Mark A. Jenkins, Lauri A. Aaltonen, David J. Kerr, Jeremy Cheadle, Paul Pharoah, Graham Casey, Richard S. Houlston & Malcolm G. Dunlop. (2011) Multiple Common Susceptibility Variants near BMP Pathway Loci GREM1, BMP4, and BMP2 Explain Part of the Missing Heritability of Colorectal Cancer. PLoS Genetics 7:6, pages e1002105.
Crossref
Jens Neumann, Evelyn Zeindl-Eberhart, Thomas Kirchner & Andreas Jung. (2009) Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Pathology - Research and Practice 205:12, pages 858-862.
Crossref
Chun WuKazuhiro MinoHidetoshi AkimotoMakiko Kawabata, Koji Nakamura, Michitaka OzakiYoshihiro Ohmiya. (2009) In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye . Proceedings of the National Academy of Sciences 106:37, pages 15599-15603.
Crossref
T. Fojo & C. Grady. (2009) How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question. JNCI Journal of the National Cancer Institute 101:15, pages 1044-1048.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.